Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COlchicine HypERtENsion Trial
2024-511391-32-00Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) and cardiac morbidity comparing Colchicin "Tiofarma" arm with Placebo arm (2 arms). Primary endpoint: Change in carotid-femoral pulse wave velocity at 6 months. Started Jul 2024; status: completed.
02
Drugs
thiamine
03
Conditions
hypertension (HTN)cardiac morbidity
Beyond the preview
Go deeper on 2024-511391-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511391-32-00.